Different Black Box Warning Labeling for Same-Class Drugs
Open Access
- 1 February 2011
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 26 (6) , 603-610
Abstract
Black box warnings (BBWs) are the strongest medication-related safety warnings in a drug’s labeling information and highlight major risks. Absence of a BBW or asynchronous addition of a BBW among same-class drugs could have major implications. We identified the 20 top-selling drugs in 2008 (10 with BBWs and 10 without BBWs on their label) that belonged to different drug classes. We collected labeling information on all drugs belonging in these 20 classes, and recorded differences in the presence and timing of acquisition of BBWs for same-class drugs. Across the 20 evaluated drug classes, we identified 176 different agents, of which 7 had been withdrawn for safety reasons. The reasons for the withdrawals became BBWs in other same-class agents only in two of the seven cases. Differences were identified in 9 of the 20 classes corresponding to 15 BBWs that were not present in all drugs of the same class. The information for 10 of the 15 different BBWs were included in the labels of same-class drugs as simple warnings or text, while it was absent entirely in 5 BBWs. The median interval from the time the BBW had appeared in another drug of the same class was 66 months. Differences in BBW labeling in same-class drugs are common and shape impressions about the safety of similar agents. BBW labeling needs to become more systematic.Keywords
This publication has 33 references indexed in Scilit:
- Inside the black box: current policies and concerns with the United States Food and Drug Administrationʼs highest drug safety warning systemCurrent Opinion in Anaesthesiology, 2010
- Adverse Drug Event Rates in Six Community Hospitals and the Potential Impact of Computerized Physician Order Entry for PreventionJournal of General Internal Medicine, 2009
- Risk Management Policy and Black-Box WarningsDrug Safety, 2009
- The New Sentinel Network — Improving the Evidence of Medical-Product SafetyNew England Journal of Medicine, 2009
- Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analysesCanadian Medical Association Journal, 2009
- Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-EpisodesPLOS ONE, 2009
- Pediatric Prescribing Practices and the FDA Black-box Warning on AntidepressantsJournal of Developmental & Behavioral Pediatrics, 2008
- PRO: The Food and Drug Administration Black Box Warning on Droperidol Is Not JustifiedAnesthesia & Analgesia, 2008
- The Continuing Dilemma of Drugs with Black Box WarningsHospital Pharmacy, 2008
- Incidence of fatal adverse drug reactions: a population based studyBritish Journal of Clinical Pharmacology, 2007